BREVICON 0.5/35 TABLETS (21-DAY PACK)
Identification of Brevicon 0.5/35 Tablets (21-Day Pack)
| No description |
Google image searchProduct monograph
Active ingredients
ethinyl estradiol, 0.035 MG
norethindrone, 0.5 MG
DIN: 02187086
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 03-FEB-2009
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03A — HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, ATC/DDD)
- G03AA — Progestogens and estrogens, fixed combinations (ATC, ATC/DDD)
- G03AA05 — NORETHISTERONE AND ESTROGEN (ATC/DDD)
Reference brand drug: Brevicon, Select
